RMBS

  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Home Equity
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Non-Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Non-Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Non-Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Non-Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Prime
  • United States
  • 8 Nov 2024
  • Assigned
  • Non-Prime
  • United States
  • 8 Nov 2024
  • Surveillance
  • Other/Esoteric
  • United Kingdom
  • 7 Nov 2024
  • Assigned
  • Prime
  • United States
  • 7 Nov 2024
  • Surveillance
  • Credit Risk Transfer
  • United States
  • 7 Nov 2024
  • Assigned
  • Non-Prime
  • United States